pharmaceutical industry

Allen Frances ‘Replies’

June 24, 2015

BACKGROUND On June 19, 2015, I published a post titled Allen Frances’ Ties to Johnson & Johnson.  In that post, I set out some very serious allegations against Dr. Frances.  I drew these allegations from a document titled Special Witness Report dated October 15, 2010.  The report was written by David Rothman, PhD, Professor of […]

Read the rest →

Allen Frances’ Ties to Johnson & Johnson

June 19, 2015

INTRODUCTION I recently came across an article titled Diagnosisgate: Conflict of Interest at the Top of the Psychiatric Apparatus, by Paula Caplan, PhD.  The article was published in Aporia, the University of Ottawa nursing journal, in January 2015.  Aporia is “a peer-reviewed, bilingual, and open access journal dedicated to scholarly debates in nursing and the […]

Read the rest →

Pharma-funded Research

September 26, 2014

On August 20, 2014, Psychiatry Advisor published an article on its website.  The article was written by Leslie Citrome, MD, a professor of psychiatry at New York Medical College in Valhalla, NY, and a member of the Board of Directors of the American Society of Clinical Psychopharmacology.  The article is called Is Bias Against Pharma-Funded […]

Read the rest →

The FDA:  The Fox Guards the Hen House

May 7, 2014

In their Fall 2013 issue, the Journal of Law, Medicine, and Ethics published a symposium of papers by members of the Harvard’s Edmond J. Safra Center for Ethics.  The symposium was called Institutional Corruption and Pharmaceutical Policy. The symposium focuses on pharmaceutical products generally, but all the material is relevant and important in the context […]

Read the rest →

Sluggish Cognitive Tempo – A New Diagnosis?

April 29, 2014

On April 11, 2014, journalist Alan Schwarz (brief bio here) published an article in the New York Times on this topic, titled Idea of New attention Disorder Spurs Research, and Debate.  Alan has written extensively on the rising rates of the condition known as ADHD, and on the abuse of the drugs that are used […]

Read the rest →

Revitalizing Psychiatric Therapeutics?

February 10, 2014

In January of this year, Steven Hyman MD, former Director of NIMH and currently a leading psychiatric researcher at MIT and Harvard, published Revitalizing Psychiatric Therapeutics in Neuropsychopharmacology.  The article is in the journal’s commentary section and is essentially an opinion piece.  Here’s Dr. Hyman’s summary: “Despite high prevalence and enormous unmet medical need, the […]

Read the rest →

Sandy Hook Massacre: The Unanswered Question

January 6, 2014

On December 27, 2013, Connecticut State Police issued a 7,000-page, heavily redacted, report on the massacre that occurred at Sandy Hook Elementary School just over a year earlier (December 14, 2012).  For the record, I have not read the 7,000-page report, but I have read the Wikipedia article Sandy Hook Elementary School shooting, last updated […]

Read the rest →

Psychiatry’s Over Reliance On Pharma

January 3, 2014

I recently read The NIMH-CATIE Schizophrenia Study: What Did We Learn? by Jeffrey Lieberman, MD, and T. Scott Stroup, MD, MPH.  The article was published in the American Journal of Psychiatry 168:8, August 2011.   Here are two quotes: “When the CATIE study was designed in 1999-2000, the prevailing opinion of researchers and clinicians alike was […]

Read the rest →

Neuroleptics for Children: Harvard’s Shame

December 4, 2013

In December 2012, Mark Olfson, MD, et al, published an article in the Archives of General Psychiatry.  The title is National Trends in the Office-Based Treatment of Children, Adolescents, and Adults with Antipsychotics.  The authors collected data from the National Ambulatory Medical Care Surveys for the period 1993-2009, and looked for trends in antipsychotic prescribing […]

Read the rest →

Care For Your Mind (CFYM): A New Advocacy Group

November 9, 2013

On September 27, Psychiatric Services, a journal of the APA, published an article called Blog Brings Doctors, Patients Together to Address MH Issues.  It was written by Vabren Watts, a Psychiatric News Journalist. The article is a booster piece for the recently-formed CFYM (Care For Your Mind): “…an online forum for people with mood disorders—along […]

Read the rest →

The Dangers of SSRI’s

November 7, 2013

SSRI’S AND SUICIDE Bob Fiddaman has a post up today called MHRA Consultant Calls for Antidepressant Use in Young.  The article highlights some of the dangers associated with SSRI’s, and also describes some of the attempts to suppress or discount the significance of this information. Apparently in 2010, Swedish psychiatrist Göran Isacsson, MD, PhD, published […]

Read the rest →

Protecting the Children

November 3, 2013

  I’ve recently read an article called Safeguarding a Generation of Children from Over-diagnosis and Prescription of Psychotropic Drugs.  It’s written by Dave Traxson, who works as an Educational Psychologist in the UK, and is posted on the  DxSummit website, an online platform for rethinking mental health, a forum in which the concepts underlying pharma-psychiatry […]

Read the rest →

The New Holy Grail: Dysfunctional Neural Circuits

October 22, 2013

There’s a new article on Psychiatric News titled Change, Challenge, and Opportunity: Psychiatry Through the Looking Glass of Research.  It’s dated October 17, and was authored  by Steven Hyman, MD, and Jeffrey Lieberman, MD.  Thanks to Mental Health Law on Twitter for the link. Dr. Lieberman is President of the APA.  Dr. Hyman was Director […]

Read the rest →

Jon Rappoport’s Blog

September 30, 2013

If you haven’t seen Jon Rappoport’s blog, please take a look.  Here are two quotes from his September 22 post, Psychiatry targets college students for destruction: “The concept called ‘mental disorder’ is a sales pitch backed up by extraordinary PR, money, academic gibberish, and government-granted official status.” “People need to wake up to the fact […]

Read the rest →

Another Mass Shooting: Link to SSRIs?

September 17, 2013

A mass murder occurred yesterday, September 16, at the U.S. Navy Yard in Washington D.C.  There are reports of at least 12 dead, and several wounded.  Early news stories describe the perpetrator as having “mental issues,” and it is reported that he “…had been treated since August by the Veterans Administration for his mental problems.”  […]

Read the rest →

The Burden of Mental ‘Illness’

September 10, 2013

Thanks to Graham Davey and Richard Pemberton on Twitter for the link to an interesting article in the August 29, 2013 issue of the Lancet.  It’s titled Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010, and was written by Harvey A. Whiteford, et […]

Read the rest →

Never Mind The Facts; Just Sell More Pills

August 23, 2013

There’s an interesting article, recently published in Journal of Contemporary Psychotherapy, on Springer Link.  It’s titled Shooting the Messenger: The Case of ADHD,  and it was written by Gretchen LeFever Watson, PhD, et al. Apparently some of the authors had noted in 1995 a marked increase in the “diagnosis” and “treatment” of the condition known […]

Read the rest →

Dr. Lieberman is Back

August 6, 2013

Courtesy of Carl Elliott via Twitter, I’ve recently read Dr. Lieberman’s latest post on Psychiatric News. It’s called – believe it or not – Time to Re-Engage With Pharma? dated August 1, 2013.  And it’s classic Dr. Lieberman sleight of hand. His opening statement, for instance, reads: “Drug companies aren’t held in high esteem by […]

Read the rest →

Pharma Mobilizing Consumer Groups Over Drug Trials Data

July 26, 2013

There was an interesting article Big pharma mobilising patients in battle over drugs trials data in last Sunday’s Guardian, a UK newspaper.  It was written by Ian Sample, the Guardian’s science correspondent.  Here are the two opening sentences: “The pharmaceutical industry has ‘mobilised’ an army of patient groups to lobby against plans to force companies […]

Read the rest →

Psychiatry Has the Moral High Ground (According to Jeffrey Lieberman)

July 2, 2013

BACKGROUND As I suppose everyone knows by now, psychiatry has been on the receiving end of some very serious criticism in recent years.  The criticism has come from many sources, including: survivors of psychiatric “treatment,” non-psychiatric mental health practitioners, journalists, the general public, and even from some psychiatrists themselves. The content of the criticisms has […]

Read the rest →

Neuroleptics in Nursing Homes

June 20, 2013

Earlier this year, The American Society of Consultant Pharmacists published a report on the use of neuroleptic drugs in nursing homes.  According to this report, 25% of nursing home residents receive neuroleptic drugs. In general, the Centers for Medicare and Medicaid Services (CMS) consider these prescriptions appropriate only if the recipient is psychotic.  (Obviously we […]

Read the rest →

Do We Really Want to Expand Mental Health Services?

June 6, 2013

PRESIDENT’S SPEECH On June 3, President Obama delivered a speech on the expansion of mental health services.  The occasion was the National Conference on Mental Health, which was held at the White House. “The truth is,” the President told us, “in any given year, one in five adults experience a mental illness — one in […]

Read the rest →

George Albee, PhD (1921-2006)

June 3, 2013

The late George Albee, psychologist, never accepted the medical model of behavioral/emotional problems.  He fought tirelessly for years to insulate psychology from the encroaching medicalization of its subject matter, and he died in 2006 believing that his efforts had failed. He authored more than 200 articles.  As early as the 50’s and 60’s, he argued […]

Read the rest →

Pharma Payments to Psychiatrists

May 31, 2013

On March 12 of this year, the Los Angeles Daily News ran an article by Susan Abram titled:  Doctors report big pharma payouts for drug endorsements.  It discusses the financial ties between physicians and drug companies in California. Here are some quotes: “In fact, hundreds of physicians, psychiatrists, and medical school faculty members across California […]

Read the rest →

Pharma Dollars Behind Mental Health Websites

May 25, 2013

There’s an interesting article on MINNPOST, Many mental-illness websites show drug-company bias, study finds, dated May 16.  The article is by Susan Perry, and presents the results of a Web survey of mental health websites conducted by John Read and A. Cain from the University of Auckland, New Zealand.  The original study was published in […]

Read the rest →

The Empire Still Fighting Back: Dr. Lieberman

May 22, 2013

Jeffrey Lieberman, MD, is president-elect of the APA, and is scheduled to take over the reins from Dr. Dilip Jeste this month.  Never in its history has the APA been subject to such scrutiny or criticism from such diverse sources, and one might reasonably have expected Dr. Lieberman to open on a conciliatory note, promising […]

Read the rest →

Psychiatry – Embracing a Social Paradigm?

May 8, 2013

There’s an interesting article in the May 2013 issue of the British Journal of Psychiatry.  It’s called “The future of academic psychiatry may be social” by Stefan Priebe, Tom Burns, and Tom K. J. Craig.  You can see it here. The abstract states: “The past 30 years have produced no discoveries leading to major changes […]

Read the rest →

Social Effect of DSM

May 5, 2013

I keep two dictionaries on my desk.  The first is a 1964 Webster’s; the second is a 2009 Webster’s.  This morning I looked up the word “depression” in both books. 1964: n. 1. a depressing or being depressed.  2. a depressed part or place; hollow or low place.  3. low spirits; dejection.  4. a decrease in […]

Read the rest →

Bereavement: An “Opportunity” for Psychiatry

May 1, 2013

There’s a new post on Mick Bramham’s website called “A time to grieve, a time to console, and a time to profit?”  You can see it here. You might have thought that, given the adverse publicity that pharma has been receiving in recent years, they would be easing up on their expansionist agenda. But you […]

Read the rest →

Suicide Risk with Antidepressants

April 28, 2013

There has been a great deal of discussion on this topic in recent years.  Families of suicide victims tend to blame the pills; the pharma companies blame the depression for which the pills were prescribed. Personally, I’ve read and heard a good many reports from people who have taken the pills and shortly afterwards experienced […]

Read the rest →

Another Good Website: by Mick Bramham

April 28, 2013

I recently came across Thinking About Mental Health: Myths, treatment risks & alternatives.  You can find it here. It’s written by Mick Bramham, from Dorset, England. Here are some quotes: From the post Depression: Serotonin Imbalance? “The whole idea of antidepressants supposedly correcting chemical imbalances has more to do with drug company marketing than evidence-based science.” […]

Read the rest →

Postpartum Depression Not an Illness

April 24, 2013

BACKGROUND The primary purpose of the bio-psychiatric-pharma faction is to expand turf and sell more drugs.  This is a multi-faceted endeavor, one component of which is disease mongering.  This consists of using marketing techniques to persuade large numbers of people that they have an illness which needs to be treated with drugs. With regards to […]

Read the rest →

The Power of Words to Shape Attitudes

April 21, 2013

I recently wrote a post called:  Do Major Tranquilizers Make Things Worse?  The post was based on a study by Drs. Harrow and Jobe in which they speculated that the high relapse rate of “schizophrenics” who stop taking their drugs may have more to do with drug withdrawal than the supposed drug efficacy. Monica, at […]

Read the rest →

Psychiatry is a Lost Cause

April 20, 2013

It is easy to vilify psychiatrists.  Their spurious conceptual framework, toxic “treatments’ and blatantly corrupt links to pharma make them easy targets.  Their destructive activities, to which they resolutely cling, invite criticism which they steadfastly ignore.  Any thoughts that perhaps they had seen the errors of their ways have been dashed by the soon-to-be published […]

Read the rest →

GPs Prescribe More Psychotropic Drugs than Psychiatrists

April 16, 2013

Psychiatrists, when challenged about the massive increase in psychotropic drug prescriptions, sometimes point out that the bulk of this prescribing is done – not by them – but by primary care doctors (GPs). Although the psychiatrists’ claim in this regards may be true, it is also somewhat misleading.  The “illnesses” for which these drugs are […]

Read the rest →

Now – by Popular Demand – Ritalin for the Elderly!

April 11, 2013

In the old days, which I well remember, misbehavior in school was considered a disciplinary problem.  This included not paying attention, fidgeting, not applying oneself to one’s work, talking, interrupting the teacher, etc., etc., etc… Then the APA decided that these various activities were really symptoms of a mental illness, and thereby created the ever-burgeoning […]

Read the rest →

Marketing Psychotropic Drugs

April 7, 2013

There’s a nice article at Involuntary Transformation on this topic. The author, Nathan, poses a very interesting question:  since drugs cause damage to children and there are many better alternatives, why do so many parents choose the drug option? Nathan goes on to suggest that the reason lies in the effort that the pharmaceutical industry […]

Read the rest →

In DSM-5, A-D-H-D Still Spells Misbehavior

April 4, 2013

It is a central theme of this website that there are no mental illnesses/disorders, and that the psychiatric medicalization of ordinary human problems is arbitrary, spurious, and destructive. The widespread acceptance of ADHD as a mental illness/chemical imbalance has no scientific underpinning, but rather is based on marketing and promotion.  The ADHD “diagnosis” is particularly […]

Read the rest →

More Conflicts of Interest in Psychiatry

April 2, 2013

I’ve come across an article by Lisa Cosgrove et al entitled Conflicts of interest and the quality of recommendations in clinical guidelines.  It was published in the Journal of Evaluation in Clinical Practice in December of last year. As everyone knows, the APA publishes the DSM, but they also publish “Clinical Practice Guidelines” for various “diagnoses,” […]

Read the rest →

Mass Murders and Mental Health

March 24, 2013

The Newtown mass murders have generated widespread demand for improved “mental health” services, and even for mandatory mental health screenings for schoolchildren.  The notion embedded in these demands is that the perpetrators are “mentally ill,” and that early identification will enable psychiatrists to treat (i.e. drug) them before they can do any damage. As I’ve […]

Read the rest →